Providence Therapeutics

Providence Therapeutics company information, Employees & Contact Information

Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENT™ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providence’s mRNA and INTENT™ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary INTENT™ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com

Company Details

Employees
60
Founded
-
Address
120, 8832 Blackfoot Trail, Calgary,alberta T2j 3j1,canada
Email
in****@****ics.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Calgary, Alberta
Looking for a particular Providence Therapeutics employee's phone or email?

Providence Therapeutics Questions

News

Providence Therapeutics Appoints Judyanna Yu as Chief Financial Officer - Yahoo Finance

Providence Therapeutics Appoints Judyanna Yu as Chief Financial Officer Yahoo Finance

Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia - PR Newswire

Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia PR Newswire

Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B - medRxiv

Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B medRxiv

Providence Therapeutics Holdings Inc. of Canada and Biological E. Limited of India announce the execution of a term sheet for the licensing and collaboration of mRNA vaccine - PR Newswire Canada

Providence Therapeutics Holdings Inc. of Canada and Biological E. Limited of India announce the execution of a term sheet for the licensing and collaboration of mRNA vaccine PR Newswire Canada

Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics - PR Newswire

Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics PR Newswire

Feds pledge $89.9M to Medicago successor Aramis and Calgary’s Providence Therapeutics - The Logic

Feds pledge $89.9M to Medicago successor Aramis and Calgary’s Providence Therapeutics The Logic

COVID-19 vaccine maker Providence says it's leaving Canada after calls for more federal support go unanswered - CBC

COVID-19 vaccine maker Providence says it's leaving Canada after calls for more federal support go unanswered CBC

CIRION and Providence Therapeutics Collaborate to Support COVID-19 Clinical Research - PR Newswire Canada

CIRION and Providence Therapeutics Collaborate to Support COVID-19 Clinical Research PR Newswire Canada

Top Providence Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant